Nebraska Center for Nanomedicine- Pilot Projects
Nebraska Center for Nanomedicine- Pilot Projects
批准号:
10163874
负责人:
David Oupicky
金额:
$34.31万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-06-01 至 2023-05-31
关键词:
Applications GrantsAreaAwardBasic ScienceBiologyCenters of Research ExcellenceClinical InvestigatorClinical ResearchCollaborationsCore FacilityDataDevelopmentDiagnosisDiagnosticDisciplineDrug Delivery SystemsEngineeringEnsureEnvironmentEvaluationExtramural ActivitiesFacultyFosteringFundingFutureGenerationsGrantGrant ReviewGrowthHypertensionImmunotherapyIncubatorsIndividualInfrastructureInterdisciplinary StudyIntervention StudiesJointsLaboratory ResearchLeadLifeMedicineMentorsMentorshipMetabolic DiseasesMissionMonitorNebraskaNotificationNucleic AcidsPhasePilot ProjectsProcessRequest for ApplicationsResearchResearch PersonnelResearch Project GrantsResearch SupportResourcesScientistSystemTeacher Professional DevelopmentUnited States National Institutes of HealthUniversitiesVaccinescancer therapycareercatalystclinical translationdesignfollow-uphuman diseaseimaging agentimprovedinnovationinterestmaterials sciencemedical specialtiesmembermultidisciplinarynanomedicinenanoparticlenovelnovel strategiesprogramsrecruitresearch studyresponsesuccesstherapeutic protein
中文摘要
摘要
在第三阶段,试点项目方案是中心使命的一个组成部分,即
继续促进教职员工的职业生涯,并在广泛的范围内促进跨学科研究
纳米医学领域,包括药物、治疗性蛋白质和核的输送项目
酸、显像剂的设计和发展及其在诊断和研究中的应用
纳米粒子的介入能力、生物学和癌症、代谢紊乱和治疗
高血压、免疫治疗和疫苗。试点方案的主要目的是(一)
为吸引更多初级和高级研究人员进入纳米医学研究领域,(2)促进
利用科学核心,(3)发展新的合作和指导关系,以
提高对外拨款申请的竞争力和成功机会
在这方面,教科文组织应与各机构合作,(Iv)鼓励开展新的方案活动,以建立该中心的长期可持续性。
该方案在第一和第二阶段的执行非常有效:发放了655,000美元
作为试点项目,我们的计划促成了总额超过2,68美元的多项外部奖励的制定
百万美元。在第三阶段的五年期间,NCN提供的1,125,000美元的NIH资金将
与75万美元的机构支持结成伙伴关系。对提案的严格评估过程是
已经到位,并涉及科学和专业人员的内部审查和优先顺序
发展局和选管会的外部审查,以确保向高收入的
可能导致校外研究支持并将刺激
多学科协作互动。核心董事将保证他们对
研究人员需要利用NCN的研究资源。描述了用于发布RFA的机制,
审查提案、通知授标、评价和监测进展情况,并采取后续行动
资助金申请。
相关性
我们中心内发生的互动和讨论促进了新想法的产生和
新方法。由创新者推动的跨学科研究,如材料科学,
工程、生物和医学将影响几乎所有的医学专业,并揭开新的面纱
提高质量和延长寿命的方法。
英文摘要
ABSTRACT
In Phase III, the Pilot Projects Program is an integral and essential part of the Center's mission to
continue to foster the careers of faculty members and promote interdisciplinary research in the broad
area of nanomedicine, encompassing projects on delivery of drugs, therapeutic proteins and nucleic
acids, design and development of imaging agents and their application for diagnostics and study of
interventional capability of nanoparticles, biology and therapy of cancer, metabolic disorders and
hypertension, immunotherapy and vaccines. The principal intents of the Pilot Project Program are (i)
to attract additional junior and senior investigators into the field of nanomedicine research, (ii) promote
utilization of the scientific cores, (iii) develop new collaborations and mentoring relationships to
enhance the competitiveness and likelihood of success of grant applications for funding to external
agencies, and (iv) stimulate new programmatic activities to build long-term sustainability of the Center.
The implementation of this program in Phases I and II was highly effective: having awarded $655,000
to pilot projects, our program has led to development of multiple external awards totaling over $2,68
million. Over the five-year span of Phase III, $1,125,000 in NIH funds provided by the NCN will be
partnered with $750,000 of institutional support. The rigorous evaluation process for the proposals is
already in place and involves internal review and prioritization by the Scientific and Professional
Development Council and external review by the EAC to ensure that funds are provided to highly
meritorious pilot projects that are likely to lead to extramural research support and will stimulate
multidisciplinary collaborative interactions. Core Directors will assure that they are responsive to the
investigator needs in utilizing NCN research resources. Mechanisms are described for issue of RFAs,
review of proposals, notification of awards, evaluation and monitoring of progress, and follow-up on
grant submissions.
RELEVANCE
The interactions and discussions that occur within our Center facilitate generation of new ideas and
new approaches. The research driven by innovators across disciplines such as material science,
engineering, biology and medicine stand to impact nearly every medical specialty and unveil novel
ways to improve the quality and extend the duration of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease
-
批准号:10356892
-
项目类别:
-
资助金额:$51.74万
-
财政年份:2020
-
负责人:David Oupicky
-
依托单位:
Chloroquine-based polymer particles as oral non-absorbable treatment of inflammatory bowel disease
-
批准号:10652269
-
项目类别:
-
资助金额:$51.74万
-
财政年份:2020
-
负责人:David Oupicky
-
依托单位:
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease
-
批准号:10207371
-
项目类别:
-
资助金额:$38.9万
-
财政年份:2019
-
负责人:David Oupicky
-
依托单位:
Development of delivery methods for combination microRNA treatment of alcohol-associated liver disease
-
批准号:9758400
-
项目类别:
-
资助金额:$38.9万
-
财政年份:2019
-
负责人:David Oupicky
-
依托单位:
Development of siRNA conjugates for combination treatment of acute kidney injury
-
批准号:9789273
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Nebraska Center for Nanomedicine- Nanomaterial Characterization Core
-
批准号:10163872
-
项目类别:
-
资助金额:$7.63万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Development of siRNA conjugates for combination treatment of acute kidney injury
-
批准号:10213017
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Development of siRNA conjugates for combination treatment of acute kidney injury
-
批准号:10434824
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Development of siRNA conjugates for combination treatment of acute kidney injury
-
批准号:9976515
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Nebraska Center for Nanomedicine
-
批准号:10163870
-
项目类别:
-
资助金额:$114.38万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Nebraska Center for Nanomedicine- Administrative Core
-
批准号:10163871
-
项目类别:
-
资助金额:$44.23万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Nebraska Center for Nanomedicine
-
批准号:10441205
-
项目类别:
-
资助金额:$114.38万
-
财政年份:2018
-
负责人:David Oupicky
-
依托单位:
Nanoparticles based on histone deacetylase inhibitors for combination treatments
-
批准号:9043064
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2015
-
负责人:David Oupicky
-
依托单位:
Dual-function nanoparticles for oral treatment of inflammatory bowel disease
-
批准号:9047281
-
项目类别:
-
资助金额:$22.67万
-
财政年份:2015
-
负责人:David Oupicky
-
依托单位:
Multilayered redox-responsive nanoparticles for delivery of drug-siRNA combinatio
-
批准号:8891423
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2014
-
负责人:David Oupicky
-
依托单位:
Multilayered redox-responsive nanoparticles for delivery of drug-siRNA combinatio
-
批准号:8701615
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2014
-
负责人:David Oupicky
-
依托单位:
Multilayered redox-responsive nanoparticles for delivery of drug-siRNA combinatio
-
批准号:9314566
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2014
-
负责人:David Oupicky
-
依托单位:
Drug-based polycations for combination drug-gene delivery
-
批准号:8614186
-
项目类别:
-
资助金额:$21.97万
-
财政年份:2013
-
负责人:David Oupicky
-
依托单位:
Drug-based polycations for combination drug-gene delivery
-
批准号:8302774
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2012
-
负责人:David Oupicky
-
依托单位:
Hollow porous silica nanoparticles for targeted drug delivery
-
批准号:7359747
-
项目类别:
-
资助金额:$18.41万
-
财政年份:2007
-
负责人:David Oupicky
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: